Statins and new onset of diabetes: which one outweighs risk or benefit?

Venu Gopal JonnalagaddaDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research, Guwahati, IndiaCorrespondence[email protected]
View further author information

Kanchan ChoudharyDepartment of Pharmacology & Toxicology, Bhupal Nobles’ Institute of Pharmaceutical Sciences, Udaipur, IndiaView further author information

Vijay Kranti MatetyDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research, Guwahati, IndiaView further author information

References

Yada T, Nakata M, Shiraishi T, et al. Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells. Br J Pharmacol. 1999;126:1205–1213.
Web of Science ®Google Scholar
Sampson UK, Linton MF, Fazio S. Are statins diabetogenic? Curr Opin Cardiol. 2011 Jul;26(4):342–347.
PubMed Web of Science ®Google Scholar
Cederberg H, Stancakova A, Yaluri N, et al. Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort. Diabetologia. 2015;58:1109–1117.
PubMed Web of Science ®Google Scholar
Koh KK, Quon MJ, Han SH, et al. Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients. Atherosclerosis. 2009 Jun;204(2):483–490.
PubMed Web of Science ®Google Scholar
Koh KK, Quon MJ, Sakuma I, et al. Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients. Int J Cardiol. 2013 Jun 20;166(2):509–515.
PubMed Web of Science ®Google Scholar
Sattar N, Taskinen MR. Statins are diabetogenic – myth or reality? Atheroscler Suppl. 2012;13:1–10.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Statins and new onset of diabetes: which one outweighs risk or benefit?

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Statins and new onset of diabetes: which one outweighs risk or benefit?

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date